VolitionRx Ltd. (NYSE:VNRX) Q3 2020 Earnings Conference Call November 13, 2020 8:30 AM ET
Company Participants
Scott Powell - EVP, IR
Cameron Reynolds - President and CEO
David Vanston - CFO
Jason Terrell - Chief Medical Officer
Conference Call Participants
Jason McCarthy - Maxim Group
Kyle Mikson - Cantor Fitzgerald
Bruce Jackson - Benchmark Company
Jason Kolbert - Dawson James
Steven Ralston - Zacks Investment Research
Operator
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to VolitionRx Limited's Third Quarter 2020 Earnings Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be opened for questions. [Operator Instructions] This conference call is being recorded today, November 13, 2020.
I'd now like to turn the conference call over to Scott Powell, Executive President of Investor Relations. Please go ahead.
Scott Powell
Thank you, and welcome everyone to today's earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the third quarter of 2020, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session. Also on our call today are Mr. Cameron Reynolds, President and Chief Executive Officer; Mr. David Vanston, Chief Financial Officer and Dr. Jason Terrell, Chief Medical Officer.
Before we begin, I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions.
- Read more current VNRX analysis and news
- View all earnings call transcripts